

To save researchers time and resources, The Michael J. Fox Foundation has made a number of tools available to the scientific community at low cost, with rapid delivery.
Helpful Resources
-
Sponsored Tools Program
Learn more about how MJFF can help share your tools.
-
Tools Consortium
MJFF is working with industry to develop priority tools.
-
Preclinical Models
Learn more about the various in vivo models used in Parkinson's disease research.
Find a Research Tool
Filter by Tool Type or Gene/Protein Type to Organize Results
* = MJFF does not control pricing or terms of availability for this tool.
Filters
VPS13C Knockout HeLa Cell Line
Immortalized Cell
HeLa cell with homozygous knockout of VPS13C.
GALC Knockout A549 Cell Line
Immortalized Cell
A549 cell with homozygous knockout of GALC.
Estimated Availability: Early 2025
ASAH1 Knockout A549 Cell Line
Immortalized Cell
A549 cell with homozygous knockout of ASAH1.
Estimated Availability: Early 2025
ATP10B Knockout LS513 Cell Line
Immortalized Cell
LS513 cell line with homozygous knockout of APT10B.
TMEM115 Antibody
Antibody
Rabbit monoclonal antibody directed against human/mouse TMEM115 for immunoprecipitation of endogenous golgi.
Estimated Availability: Mid 2026
OMP25 Antibody
Antibody
Rabbit monoclonal antibody directed against human/mouse OMP25 for immunoprecipitation of endogenous mitochondria.
Estimated Availability: Late 2025
TMEM192 Antibody
Antibody
Rabbit monoclonal antibody directed against human/mouse TMEM192 for immunoprecipitation of endogenous lysosomes.
Estimated Availability: Late 2025
Alpha-Synuclein Filament-Specific Antibody
Antibody
Conformation-specific rabbit monoclonal antibody directed against the filamentous form of wild-type alpha-synuclein.
ATP13A2 Antibody
Antibody
Rabbit monoclonal antibody directed against human ATP13A2 for immunoblotting, immunostaining, and immunoprecipitation applications.
Estimated Availability: Early 2026
ATP10B Antibody
Antibody
Rabbit monoclonal antibody directed against human/mouse ATP10B for immunoblotting and immunostaining applications.
Estimated Availability: Early 2025
Have questions or need additional information?
Email tools@michaeljfox.org with questions and to suggest new tools for us to develop. Or visit our FAQ page.
"We have shown, thanks in part to MJFF, that researchers now have in their pantry the right ‘ingredients’, to... help to drive forward PD drug development.”
Heather Melrose, PhD
Mayo Clinic